Categories: Tech

Extraordinary general meeting in IDEX Biometrics held on 9

Published by
Globe News Wire


IDEX Biometrics ASA held an extraordinary general meeting on 9 December 2022. 376.8 million shares or 34% of the capital was represented at the meeting.

All resolutions were passed as proposed in the notice of the meeting.

The general meeting resolved to issue the Tranche 2 shares of the private placement disclosed on 16 November 2022. 48,745,135 new shares will be issued at NOK 1.00 per share. Following the issue of the Tranche 2 shares, the company’s share capital is NOK 174,948,987.60 divided into 1,166,326.584 shares each with a nominal value of NOK 0.15.

The minutes of the meeting will be available at the company’s web site, www.idexbiometrics.com, in due course.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 9180 0186

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal touch-free authentication for all.  We help people make payments, prove their identity, gain access to information, unlock devices, or gain admittance to buildings with the touch of a finger. We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions.  Our total addressable market represents a fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter @IDEXBiometrics

About this notice
This information s disclosed according to the continuing obligations for companies listed on Euronext Oslo Børs, by Erling Svela, Vice president of finance, on 9 December 2022 at 11:30 CET on behalf of IDEX Biometrics ASA.

Globe News Wire

Recent Posts

AERWINS Technologies Inc. and PONO Capital Corp. Complete

HONOLULU and TOKYO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- AERWINS Technologies Inc. (“AERWINS” or the… Read More

19 mins ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals,… Read More

20 mins ago

Sarissa Capital Highlights Amarin’s Disregard for Shareholder Interests and Urges Shareholders to Vote the BLUE Proxy Card for Change at Amarin

Sarissa launches website www.freeamarin.com and posts presentation for shareholders Sarissa urges shareholders to vote the… Read More

21 mins ago

Miner Orb Introduces a New, Secure Way of Purchasing

Nevada, Texas, United States, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Summary: Miner Orb has emerged as… Read More

1 hour ago

Arcutis Biotherapeutics Reports Inducement Grants Under

WESTLAKE VILLAGE, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early… Read More

1 hour ago

Firsthand Technology Value Fund Discloses Preliminary NAV of $4.44 Per Share as of December 31, 2022

Top Holdings Include IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital SAN JOSE, Calif.--(BUSINESS… Read More

1 hour ago